image
Clearside Biomedical, Inc. CLSD
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.8453
-1.82 %
$ 65.2 M
Market Cap
-1.8
P/E
BALANCE SHEET
25.1 M ASSETS
-26.14%
Growth Rates
1Year -26.14%
3Years -16.33%
5Years -1.26%
7Years -6.59%
10Years 9.33%
64 M LIABILITIES
28.14%
Growth Rates
1Year 28.14%
3Years 135.03%
5Years 32.58%
7Years 18.87%
10Years 8.05%
-38.9 M EQUITY
-144.19%
Growth Rates
1Year -144.19%
3Years -26.48%
5Years -34.99%
7Years -15.93%
10Years -7.30%
BALANCE SHEET DECOMPOSITION
Balance Sheet Clearside Biomedical, Inc.
image
Current Assets 21.3 M
Cash & Short-Term Investments 20 M
Receivables 507 K
Other Current Assets 747 K
Non-Current Assets 3.85 M
Long-Term Investments 0
PP&E 3.82 M
Other Non-Current Assets 30 K
79.68 %2.97 %15.21 %Total Assets$25.1m
Current Liabilities 4.79 M
Accounts Payable 1.45 M
Short-Term Debt 375 K
Other Current Liabilities 2.97 M
Non-Current Liabilities 59.2 M
Long-Term Debt 328 K
Other Non-Current Liabilities 58.9 M
4.64 %91.99 %Total Liabilities$64.0m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 20.0 28.9 48.3 30.4 17.3 22.6 8.0 9.2 34.8 20.3 8.3 1.9 0.9
Short Term Investments 0 0 0 0 0 0 32.8 28.4 48.8 0 0 0 0
Receivables 0.5 0.2 0 10.0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0.9 0 0 0 0 0 0 0 0 0
Other Current Assets 0.7 1.0 1.1 1.7 0.8 2.6 2.1 1.6 0.7 0.2 54 K 0.1 27 K
Total Current Assets 21.3 30.1 48.3 42.1 18.1 25.2 42.9 37.6 83.6 20.5 8.3 2.0 0.9
PP&E 3.8 3.9 1.9 0.6 0.9 1.2 0.8 0.9 94 K 0.2 0.2 98 K 50 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 30 K 0.2 0.3 0.4 0.4 0.4 0.4 0 0 0 0
Other Long Term Assets 30 K 30 K 1.1 0 0 0 26 K (0.9) 94 K 0.4 1.8 22 K 50 K
Other Assets 0 0 0 0 0 0 0 2.5 0.8 0 0 0 15 K
Total Assets 25.1 34.0 51.3 42.9 19.3 26.8 44.1 40.5 84.8 21.1 10.3 2.1 0.9
LIABILITIES
Accounts Payable 1.5 2.2 1.1 0.9 2.0 1.3 6.9 5.4 2.6 1.5 1.3 0.2 0
Short Term Debt 0.4 0.4 0.7 0.8 1.7 2.1 0.6 3.2 0 1.7 0 0 0
Other Current Liabilities 3.0 4.2 3.8 2.9 1.2 2.6 3.1 4.9 2.8 2.0 1.2 0.4 0.5
Total Current Liabilities 4.8 6.8 5.8 4.6 9.9 10.9 10.5 13.5 5.4 5.2 2.4 0.7 0.5
Long Term Debt 0.3 42.6 0.9 0.3 0.6 4.7 9.4 4.8 7.6 4.2 0 0.3 0.1
Deferred Tax Income 0 0 0 0 0 0 0 (0.8) (0.3) 47.3 0 0 0
Other Liabilities 58.9 0.5 34.0 0 0 0 0.6 0.6 0 0.3 26.9 11.9 0
Total Liabilities 64.0 49.9 40.7 4.9 10.6 15.6 20.5 19.1 13.2 57.7 29.5 12.9 0.7
EQUITY
Common Stock 77 K 63 K 61 K 60 K 52 K 44 K 32 K 25 K 25 K 3 K 4 K 3 K 2 K
Retained Earnings (355.3) (320.9) (288.4) (255.5) (255.9) (237.7) (206.9) (124.2) (65.2) (39.4) (21.7) (11.5) (4.3)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 0 8 K 13 K (0.1) 55 K 22 K 0
Total Equity (38.9) (15.9) 10.6 38.0 8.8 11.2 23.6 21.4 71.7 (36.7) (19.2) (10.7) 0.2
Total Liabilities and Equity 25.1 34.0 51.3 42.9 19.3 26.8 44.1 40.5 84.8 21.1 10.3 2.1 0
SHARES OUTSTANDING
Common Shares Outstanding 73.8 61.8 60.2 58.5 46.5 38.2 30.7 25.3 13.1 12.3 12.3 12.3 0.8